Search Results - "Pass H"

This result is not displayed to guests.
Login for full access.

Rudder pedal-force characteristics.

Authors: Pass, H. R.

Source: Journal of the Aeronautical Sciences.; April 1944, Vol. 11, p183-187, 5p

New developments about the association of SV40 with human mesothelioma.

Authors: Carbone, M Pass, H I Miele, L et al.

Source: Oncogene. 8/11/2003 Review, Vol. 22 Issue 33, p5173-5180. 8p.

Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.

Authors: Lucas, D R Pass, H I Madan, S K et al.

Source: Histopathology. Mar2003, Vol. 42 Issue 3, p270-279. 10p.

970TiP SKYSCRAPER-05: Phase II study of neoadjuvant atezolizumab (Atezo) + tiragolumab (Tira) with or without platinum-based chemotherapy (CT) in patients (Pts) with locally advanced resectable stage II‒IIIB NSCLC.

Authors: Pass, H. Kim, A.W. Felip, E. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS990-S991. 2p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Pesticides, how formulation problems are being solved.

Authors: Pass, H. A. Pearce, D. A.

Source: Canadian Chemical Processing; January 1955, Vol. 39, p48

Pesticides, how formulation problems are being solved.

Authors: Pass, H. A. Pearce, D. A.

Source: Canadian Chemical Processing; December 1954, Vol. 38, p54

Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.

Authors: Frey, A. B. Wali, A. Pass, H. et al.

Source: Histopathology. May2007, Vol. 50 Issue 6, p720-726. 7p. 2 Diagrams, 2 Charts.

P-407 A multicenter phase 2 trial of neo-adjuvant pemetrexed pluscisplatin followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM)

Authors: Krug, L. Pass, H. Rusch, V. et al.

Source: Lung Cancer (01695002). Jul2005 Supplement 2, Vol. 49, pS222-S222. 1p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Authors: Cioce, M Ganci, F Canu, V et al.

Source: Oncogene. 11/13/2014, Vol. 33 Issue 46, p5319-5331. 13p. 1 Chart, 6 Graphs.

Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma.

Authors: Guo, Y Chirieac, L R Bueno, R et al.

Source: Oncogene. 6/12/2014, Vol. 33 Issue 24, p3151-3160. 10p.

Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.

Authors: Goparaju, C M Blasberg, J D Volinia, S et al.

Source: Oncogene. 6/16/2011, Vol. 30 Issue 24, p2767-2777. 11p. 4 Black and White Photographs, 1 Diagram, 1 Chart, 4 Graphs.

The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival.

Authors: Cheung, M. Pei, J. Pei, Y. et al.

Source: Oncogene. 3/18/2010, Vol. 29 Issue 11, p1633-1640. 8p. 4 Graphs.

Eighth International Mesothelioma Interest Group.

Authors: Carbone, M. Albelda, S. M. Broaddus, V. C. et al.

Source: Oncogene. 10/25/2007, Vol. 26 Issue 49, p6959-6967. 9p. 3 Black and White Photographs.

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

Authors: Ohta, Y Shridhar, V Bright, R K et al.

Source: British Journal of Cancer. 9/1/99, Vol. 81 Issue 1, p54. 8p.

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.

Authors: Izumchenko, E. Paz, K. Ciznadija, D. et al.

Source: Annals of Oncology. Oct2017, Vol. 28 Issue 10, p2595-2605. 11p. 1 Diagram, 1 Chart, 4 Graphs.